Pharmaceutical Patent Analyst
MEDLINE-indexed journal on recent patents discussed within the context of other R&D advances
CiteScore: 0.66 (2015) | SJR: 0.369 (2015)
Pharmaceutical Patent Analyst is dedicated to making the essential content of key patents available in a concise and enriched format to researchers and other specialists, while also providing timely commentary on important issues related to patent and IP law.
As one of the main drivers of innovation, in both academia and industry, patents are a rich source of technical information about the latest advances in the discovery and design of novel therapeutics and healthcare products.
The journal’s core content therefore comprises high-impact patent reviews that provide an objective and concise appraisal of selected patents in a chosen area, set within the context of the wider relevant R&D landscape. Articles exploring patenting trends as well as those examining new methodologies for searching the patent literature also feature.
Complementing the core scientific review content of each issue will be news updates, editorials, interviews and hot topic articles presenting enlightened opinion and commentary on pressing IP issues related to the pharmaceutical patent lifecycle or to R&D more broadly.
Pharmaceutical Patent Analyst is principally targeted at researchers and scientists who need to remain abreast of developments in the patent literature, while additionally enhancing their understanding of associated IP issues. In addition, the journal will appeal to those outside the research community, notably IP specialists, legal professionals and technology-transfer officers.
Coverage in brief
Analyses of the patent literature
Reviews examining patents of relevance to all therapeutic areas will be accepted, including:
A guide to writing patent reviews is available here.
Articles dedicated the following will also be considered:
Commentary on IP issues
Perspectives and analysis on IP/patent law issues of importance to the patent lifecycle, or to pharmaceutical and medical R&D more broadly.
Indexed in: Chemical Abstracts; EMBASE/Excerpta Medica; Emerging Sources Citation Index (Web of Science); MEDLINE/Index Medicus; Scopus
Current Volume: Volume 6 (2017)
Issues per Year: 6
Average Abstract Views: 3,432 (June 2015 - May 2016)
Open Access Option: Yes
Average Lead Time to Online Publication: 14 - 16 weeks
Rapid Publication Option: Yes